ClinConnect ClinConnect Logo
Search / Trial NCT06222983

Efficacy and Prognosis of Surgical Intervention in Patients With Carotid Artery Stenosis

Launched by XUANWU HOSPITAL, BEIJING · Jan 24, 2024

Trial Information

Current as of June 12, 2025

Recruiting

Keywords

Carotid Revascularization Carotid Artery Stenting Carotid Endarterectomy

ClinConnect Summary

This clinical trial is studying the effectiveness and safety of two surgical methods, carotid artery stenting (CAS) and carotid endarterectomy (CEA), for patients who have severe narrowing of the carotid artery due to plaque buildup. The researchers aim to understand the characteristics of high-risk plaque and how well these surgical options work for patients with significant artery blockage. By looking at both imaging tests and the actual plaque that is removed during surgery, they hope to find the best approach for treating patients with carotid artery stenosis.

To participate in this trial, you should be between 45 and 85 years old and have a specific level of artery narrowing—either more than 50% if you have symptoms or between 70% and 99% if you don’t. If you join, you can expect to undergo regular check-ups and contribute to important research that may help improve treatment for others with similar conditions. Your participation will help doctors better understand which surgical method might be safer and more effective for patients with high-risk plaque.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. The patient is aged 45-85 years old;
  • 2. Symptomatic patients with stenosis degree greater than 50%, or asymptomatic patients with stenosis degree between 70% and 99% (ultrasound, CT or contrast);
  • 3. Can complete regular follow-up;
  • 4. The patient is informed and agrees to participate in the study.
  • Exclusion Criteria:
  • -

About Xuanwu Hospital, Beijing

Xuanwu Hospital, located in Beijing, is a leading clinical research institution renowned for its commitment to advancing medical knowledge and improving patient care. Affiliated with Capital Medical University, the hospital specializes in neurology and rehabilitation, providing a robust framework for innovative clinical trials. With a multidisciplinary team of experienced researchers and healthcare professionals, Xuanwu Hospital focuses on conducting high-quality, ethically sound studies that aim to explore new treatment modalities and enhance therapeutic outcomes. Through its dedication to research excellence and patient-centered approaches, Xuanwu Hospital plays a pivotal role in the advancement of healthcare solutions both locally and globally.

Locations

Beijing, , China

Patients applied

0 patients applied

Trial Officials

Lianrui Guo

Principal Investigator

Xuanwu Hospital, Beijing

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported